H&R Block vs Regis
HRB and RGS side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HRB and RGS compare
H&R Block is the larger company, worth 113 times as much as Regis ($5.9B against $52.5M).
On earnings, H&R Block is cheaper: it trades at 8.5× trailing earnings, against 8.7× for Regis.
Regis grew revenue faster over the last twelve months (6.8% versus 4.9% for H&R Block).
H&R Block keeps more of each dollar of sales as profit, with a net margin of 18.6% compared with 3.1% at Regis.
H&R Block pays a dividend yielding 3.6%; Regis does not pay one.
H&R Block scores higher on the StockData Score (18 against 6 for Regis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HRB | RGS |
|---|---|---|
| Size and price | ||
| Market cap | $5.9B | $52.5M |
| Share price | $48.07 | $21.02 |
| Change, 1 year | 8.6% | −19.6% |
| Change, 5 years | 92.0% | −63.6% |
| Beta (5Y) | 0.30 | 0.89 |
| Employees | 4,600 | 1,611 |
| StockData Score | ||
| Total score | 18 (better) | 6 |
| Valuation score | 5 | 5 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 8.5× (better) | 8.7× |
| P/S | 1.5× | 0.2× (better) |
| P/B | 50.4× | 0.3× (better) |
| EV/EBITDA | 6.1× | 5.1× (better) |
| P/FCF | 7.8× | 4.7× (better) |
| PEG | 0.49 | – |
| FCF yield | 12.8% | 21.2% (better) |
| Fair value | $78.17 | $52.31 |
| Margin of safety | 38.5% | 59.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.9% | 6.8% (better) |
| Revenue growth, 5Y average | 8.4% (better) | −11.4% |
| Net income growth (TTM) | 21.1% (better) | −94.4% |
| EPS growth (TTM) | 28.9% | – |
| Profitability | ||
| Gross margin | 44.3% | – |
| Operating margin | – | 10.9% |
| Net margin | 18.6% (better) | 3.1% |
| FCF margin | 19.2% (better) | 5.0% |
| Return on equity | 711% (better) | 3.7% |
| Return on invested capital | – | 8.7% |
| Financial health | ||
| Debt / equity | 12.69 | 0.60 (better) |
| Net debt / EBITDA | 0.50 (better) | 3.22 |
| Interest coverage | – | 1.2× |
| Current ratio | 1.13 (better) | 0.62 |
| Altman Z-score | 2.41 (better) | 0.85 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 3.6% | – |
| Payout ratio | 28.8% | – |
| Years of dividend growth | 4 | – |
| Dividend growth, 5Y average | 10.1% | – |
| Buyback yield | – | −1.2% |
| Shareholder yield | 3.6% (better) | −1.2% |
| Ownership | ||
| Held by institutions | 104% | 31.0% |
| Held by insiders | 1.7% | 13.8% |
| Insider net buying, 12 months | −$110K | −$14.0K (better) |
| Short interest, % of float | 13.9% | 2.0% |
Go deeper
- HRB stock overview
- HRB income statement
- HRB valuation and score
- RGS stock overview
- RGS income statement
- RGS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.